These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 20701670
1. Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. Tipton DA, Seshul BA, Dabbous MKh. J Periodontal Res; 2011 Feb; 46(1):39-47. PubMed ID: 20701670 [Abstract] [Full Text] [Related]
2. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT. Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542 [Abstract] [Full Text] [Related]
3. Mechanical force augments the anti-osteoclastogenic potential of human gingival fibroblasts in vitro. Kook SH, Son YO, Choe Y, Kim JH, Jeon YM, Heo JS, Kim JG, Lee JC. J Periodontal Res; 2009 Jun; 44(3):402-10. PubMed ID: 18842115 [Abstract] [Full Text] [Related]
4. Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. Stein SH, Dean IN, Rawal SY, Tipton DA. J Periodontal Res; 2011 Aug; 46(4):483-90. PubMed ID: 21463327 [Abstract] [Full Text] [Related]
5. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Wada N, Maeda H, Yoshimine Y, Akamine A. Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598 [Abstract] [Full Text] [Related]
6. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732 [Abstract] [Full Text] [Related]
7. Alendronate regulates cytokine production induced by lipid A through nuclear factor-κB and Smad3 activation in human gingival fibroblasts. Tamai R, Sugiyama A, Kiyoura Y. J Periodontal Res; 2011 Feb; 46(1):13-20. PubMed ID: 20663020 [Abstract] [Full Text] [Related]
8. Local osteoprotegerin gene transfer to periodontal tissue inhibits lipopolysaccharide-induced alveolar bone resorption. Chen R, Kanzaki H, Chiba M, Nishimura M, Kanzaki R, Igarashi K. J Periodontal Res; 2008 Apr; 43(2):237-45. PubMed ID: 18086145 [Abstract] [Full Text] [Related]
9. The effects of bisphosphonates on osteoblasts in vitro. Naidu A, Dechow PC, Spears R, Wright JM, Kessler HP, Opperman LA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):5-13. PubMed ID: 18504149 [Abstract] [Full Text] [Related]
10. Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling. Kook SH, Son YO, Hwang JM, Kim EM, Lee CB, Jeon YM, Kim JG, Lee JC. J Cell Biochem; 2009 Apr 15; 106(6):1010-9. PubMed ID: 19206164 [Abstract] [Full Text] [Related]
11. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. Reyes-García R, Muñoz-Torres M, García DF, Mezquita-Raya P, García Salcedo JA, de Dios Luna J. Menopause; 2010 Apr 15; 17(1):140-4. PubMed ID: 19574937 [Abstract] [Full Text] [Related]
12. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R. Bone; 2007 Feb 15; 40(2):457-63. PubMed ID: 16979395 [Abstract] [Full Text] [Related]
13. Dual modulation of osteoclast differentiation by lipopolysaccharide. Zou W, Bar-Shavit Z. J Bone Miner Res; 2002 Jul 15; 17(7):1211-8. PubMed ID: 12096834 [Abstract] [Full Text] [Related]
14. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT. J Rheumatol; 2005 Apr 15; 32(4):713-20. PubMed ID: 15801030 [Abstract] [Full Text] [Related]
15. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. Açil Y, Möller B, Niehoff P, Rachko K, Gassling V, Wiltfang J, Simon MJ. J Craniomaxillofac Surg; 2012 Dec 15; 40(8):e229-35. PubMed ID: 22082730 [Abstract] [Full Text] [Related]
16. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Aubin JE, Bonnelye E. Medscape Womens Health; 2000 Mar 15; 5(2):5. PubMed ID: 10792853 [Abstract] [Full Text] [Related]
17. Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. Krajewski AC, Biessei J, Kunze M, Maersch S, Perabo L, Noack MJ. APMIS; 2009 Oct 15; 117(10):746-54. PubMed ID: 19775343 [Abstract] [Full Text] [Related]
18. Regulatory roles of beta-catenin and AP-1 on osteoprotegerin production in interleukin-1alpha-stimulated periodontal ligament cells. Suda T, Nagasawa T, Wara-Aswapati N, Kobayashi H, Iwasaki K, Yashiro R, Hormdee D, Nitta H, Ishikawa I, Izumi Y. Oral Microbiol Immunol; 2009 Oct 15; 24(5):384-9. PubMed ID: 19702951 [Abstract] [Full Text] [Related]
20. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease. Liu W, Feng W, Wang F, Li W, Gao C, Zhou B, Ma M. Exp Mol Pathol; 2008 Jun 15; 84(3):213-7. PubMed ID: 18417124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]